Fiche centre
Johns Hopkins Medicine
Baltimore — United States
Essais liés4clinical trials
VilleBaltimorelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07521930
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Surgical implantation of CortiCom system | Sclérose latérale amyotrophique | Non applicable | NCT03567213 | Investigation on the Cortical Communication (CortiCom) System | RECRUITING |
| Ocrelizumab | SEP | Phase 3 | NCT05123703 | Operetta 2 — A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) | ACTIVE_NOT_RECRUITING |
| INTENT Neural Interface System | Sclérose latérale amyotrophique | Non applicable | NCT07521930 | Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT) | RECRUITING |
| embolization of middle meningeal arteries | Migraine | Non applicable | NCT07223008 | MMAE-Migraine — Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine | RECRUITING |